Annual Net Income
-$47.97 M
+$99.59 M+67.49%
December 31, 2023
Summary
- As of February 10, 2025, GTHX annual net profit is -$47.97 million, with the most recent change of +$99.59 million (+67.49%) on December 31, 2023.
- During the last 3 years, GTHX annual net income has risen by +$51.29 million (+51.67%).
Performance
GTHX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Net Income
-$5.47 M
+$4.75 M+46.48%
June 30, 2024
Summary
- As of February 10, 2025, GTHX quarterly net profit is -$5.47 million, with the most recent change of +$4.75 million (+46.48%) on June 30, 2024.
- Over the past year, GTHX quarterly net income has dropped by -$14.18 million (-162.79%).
Performance
GTHX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Net Income
-$44.77 M
-$14.18 M-46.35%
June 30, 2024
Summary
- As of February 10, 2025, GTHX TTM net profit is -$44.77 million, with the most recent change of -$14.18 million (-46.35%) on June 30, 2024.
- Over the past year, GTHX TTM net income has increased by +$33.04 million (+42.46%).
Performance
GTHX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
GTHX Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +67.5% | -162.8% | +42.5% |
| 3 y3 years | +51.7% | -162.8% | +42.5% |
| 5 y5 years | +43.8% | +82.2% | +65.6% |
GTHX Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +209.3% | -162.8% | +799.5% | +46.4% | +282.2% |
| 5 y | 5-year | at high | +209.3% | -162.8% | +799.5% | +46.4% | +282.2% |
| alltime | all time | +136.7% | +209.3% | -162.8% | +799.5% | +651.9% | +282.2% |
G1 Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | - | -$5.47 M(-46.5%) | -$44.77 M(+46.4%) |
| Mar 2024 | - | -$10.22 M(-6.1%) | -$30.59 M(-36.2%) |
| Dec 2023 | -$47.97 M(-67.5%) | -$10.88 M(-40.2%) | -$47.97 M(-32.2%) |
| Sep 2023 | - | -$18.20 M(-309.0%) | -$70.74 M(-9.1%) |
| Jun 2023 | - | $8.71 M(-131.6%) | -$77.81 M(-38.2%) |
| Mar 2023 | - | -$27.59 M(-18.0%) | -$125.96 M(-14.6%) |
| Dec 2022 | -$147.56 M(-0.5%) | -$33.65 M(+33.1%) | -$147.56 M(-4.1%) |
| Sep 2022 | - | -$25.27 M(-35.9%) | -$153.93 M(-10.0%) |
| Jun 2022 | - | -$39.45 M(-19.8%) | -$171.13 M(+0.0%) |
| Mar 2022 | - | -$49.19 M(+22.9%) | -$171.10 M(+15.3%) |
| Dec 2021 | -$148.35 M(+49.5%) | -$40.02 M(-5.8%) | -$148.35 M(+11.0%) |
| Sep 2021 | - | -$42.47 M(+7.7%) | -$133.68 M(+29.9%) |
| Jun 2021 | - | -$39.42 M(+49.1%) | -$102.89 M(+8.7%) |
| Mar 2021 | - | -$26.44 M(+4.3%) | -$94.67 M(-4.6%) |
| Dec 2020 | -$99.25 M | -$25.35 M(+117.1%) | -$99.25 M(-9.2%) |
| Sep 2020 | - | -$11.67 M(-62.6%) | -$109.35 M(-15.9%) |
| Jun 2020 | - | -$31.21 M(+0.6%) | -$130.04 M(+0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$31.02 M(-12.5%) | -$129.52 M(+5.8%) |
| Dec 2019 | -$122.45 M(+43.6%) | -$35.44 M(+9.5%) | -$122.45 M(+10.2%) |
| Sep 2019 | - | -$32.36 M(+5.5%) | -$111.10 M(+12.6%) |
| Jun 2019 | - | -$30.69 M(+28.1%) | -$98.65 M(+11.1%) |
| Mar 2019 | - | -$23.95 M(-0.6%) | -$88.83 M(+4.2%) |
| Dec 2018 | -$85.29 M(+41.9%) | -$24.09 M(+21.0%) | -$85.29 M(+9.1%) |
| Sep 2018 | - | -$19.92 M(-4.6%) | -$78.18 M(+5.8%) |
| Jun 2018 | - | -$20.87 M(+2.2%) | -$73.86 M(+8.3%) |
| Mar 2018 | - | -$20.41 M(+20.2%) | -$68.19 M(+13.4%) |
| Dec 2017 | -$60.12 M(+98.5%) | -$16.98 M(+8.8%) | -$60.12 M(+12.3%) |
| Sep 2017 | - | -$15.60 M(+2.7%) | -$53.54 M(+20.3%) |
| Jun 2017 | - | -$15.19 M(+23.1%) | -$44.50 M(+21.3%) |
| Mar 2017 | - | -$12.35 M(+18.7%) | -$36.68 M(+21.1%) |
| Dec 2016 | -$30.29 M(+49.5%) | -$10.40 M(+58.6%) | -$30.29 M(+52.3%) |
| Sep 2016 | - | -$6.56 M(-11.1%) | -$19.89 M(+49.2%) |
| Jun 2016 | - | -$7.38 M(+23.9%) | -$13.33 M(+123.9%) |
| Mar 2016 | - | -$5.95 M | -$5.95 M |
| Dec 2015 | -$20.26 M | - | - |
FAQ
- What is G1 Therapeutics annual net profit?
- What is the all time high annual net income for G1 Therapeutics?
- What is G1 Therapeutics annual net income year-on-year change?
- What is G1 Therapeutics quarterly net profit?
- What is the all time high quarterly net income for G1 Therapeutics?
- What is G1 Therapeutics quarterly net income year-on-year change?
- What is G1 Therapeutics TTM net profit?
- What is the all time high TTM net income for G1 Therapeutics?
- What is G1 Therapeutics TTM net income year-on-year change?
What is G1 Therapeutics annual net profit?
The current annual net income of GTHX is -$47.97 M
What is the all time high annual net income for G1 Therapeutics?
G1 Therapeutics all-time high annual net profit is -$20.26 M
What is G1 Therapeutics annual net income year-on-year change?
Over the past year, GTHX annual net profit has changed by +$99.59 M (+67.49%)
What is G1 Therapeutics quarterly net profit?
The current quarterly net income of GTHX is -$5.47 M
What is the all time high quarterly net income for G1 Therapeutics?
G1 Therapeutics all-time high quarterly net profit is $8.71 M
What is G1 Therapeutics quarterly net income year-on-year change?
Over the past year, GTHX quarterly net profit has changed by -$14.18 M (-162.79%)
What is G1 Therapeutics TTM net profit?
The current TTM net income of GTHX is -$44.77 M
What is the all time high TTM net income for G1 Therapeutics?
G1 Therapeutics all-time high TTM net profit is -$5.95 M
What is G1 Therapeutics TTM net income year-on-year change?
Over the past year, GTHX TTM net profit has changed by +$33.04 M (+42.46%)